Global Cardiovascular Prosthetic Products Market Growth (Status and Outlook) 2024-2030

Global Cardiovascular Prosthetic Products Market Growth (Status and Outlook) 2024-2030

Cardiovascular Prosthetic Products are implantable or external devices that replace or assist parts of the cardiovascular system, such as the heart, arteries, or veins. Examples of cardiovascular prosthetic devices include pacemakers, implanted heart valves, artificial vascular grafts, and stents. These devices significantly improve quality of life and are normally installed by a heart surgeon. They are also used to treat a number of cardiac conditions, including valvular heart disease, congenital heart defects, arrhythmias, coronary artery disease, and heart failure. Aortic aneurysm repair, valve replacement, endovascular stenting, ventricular assist devices, transcatheter aortic valve replacement (TAVR), and other procedures all involve these cardiovascular prosthetic devices.

The global Cardiovascular Prosthetic Products market size is projected to grow from US$ 28860 million in 2024 to US$ 48100 million in 2030; it is expected to grow at a CAGR of 8.9% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Cardiovascular Prosthetic Products Industry Forecast” looks at past sales and reviews total world Cardiovascular Prosthetic Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Prosthetic Products sales for 2023 through 2029. With Cardiovascular Prosthetic Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Prosthetic Products industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Prosthetic Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cardiovascular Prosthetic Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiovascular Prosthetic Products market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Prosthetic Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Prosthetic Products.

According to report shared by Center for Disease Control and Prevention (CDC), in 2020, it was stated that, coronary heart disease is the most common type of heart disease, killing 382,820 people in U.S. Moreover, in 2020, about 2 in 10 deaths from coronary artery disease (CAD) happen in adults less than 65 years old. Increase in number of cardiovascular surgeries is anticipated to drive the application of cardiovascular prosthetic devices and boosts market growth. For instance, according to National Library of Medicine in September 2022, it was reported that, more than 200,000 heart valve replacement surgeries are performed annually worldwide, with a predicted increment to 8,50,000 per year by 2050. In addition, according to National Library of Medicine in August 2022, almost 400,000 coronary artery bypass grafting (CABG) surgeries are performed each year making it the most-performed major surgical procedure.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Prosthetic Products market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cardiac Prosthetic Products
Vascular Prosthetic Products

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Cardiac Prosthetic Products
Vascular Prosthetic Products

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
B Braun Melsungen AG
Boston Scientific Corporation
Biotronic
W. L. Gore & Associates, Inc
Artivion, Inc
Johnson and Johnson
Medtronic Plc
Meril Life Sciences Pvt. Ltd
Edwards Lifesciences
Terumo Group
Maquet Cardiovascular
Gore
Nicast
Bard
Jude Medical
LeMaitre Vascular
Lifetech Scientific
BiVACOR
SynCardia
Jarvik Heart, Inc
CARMAT
AbioMed

Please note: The report will take approximately 2 business days to prepare and deliver.